Insiders · Profile

Swirsky Douglas J

CHIEF FINANCIAL OFFICER at MAXCYTE · Director at Cellectar Biosciences · President and CEO at Opus Genetics. Filing since 29 Jan 2019. CIK 0001375884

Company
Date
Role
Action
Shares
Amount
Of holding
17 Mar 2026
CHIEF FINANCIAL OFFICER
Sold at will
10,142
$8.27K
6.3%
13 Aug 2025
CHIEF FINANCIAL OFFICER
Bought
50,000
$64.50K
44.7%
18 Mar 2025
CHIEF FINANCIAL OFFICER
Sold at will
6,939
$22.06K
5.8%
14 Sep 2021
Director
Bought
25,000
$26.00K
opened
29 Jan 2019
President and CEO
Bought
50,000
$31.72K
opened
5 decisions on file.